KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

SBRI funding competition: vaccines for global epidemics – Pre-clinical

The Department of Health is to invest up to £25 million to develop new vaccines against infectious diseases in line with the priorities identified by the UK Vaccine Network.

Vaccines are among the most cost-effective medical countermeasure for confronting epidemics or pandemics. Their effectiveness in preventing disease outbreaks has been far-reaching, and their availability could significantly reduce fatalities. Rapid manufacture, deployment and delivery of these vaccines in resource-poor settings are key to containing the spread of disease.

This competition aims to support the preclinical development of candidate vaccines against 12 diseases (listed below). The UK Vaccine Network has identified these diseases as a priority as they have the potential to cause epidemics in low and middle-income countries.


·      Chikungunya

·      Crimean-Congo Haemorrhagic Fever

·      Ebola

·      Hantavirus

·      Lassa

·      Marburg

·      Middle East Respiratory Syndrome

·      Nipah

·      Plague

·      Rift Valley Fever and

·      Zika

  • Q fever


This competition will support projects seeking to develop candidate vaccines and vaccine platform technologies at the preclinical stage to enable a rapid and effective response to epidemic or pandemic threats.


The competition has two stages:

  • Stage 1: exploring the scientific, technical and commercial feasibility of candidate vaccines and vaccine technologies. We expect projects to last for up to 12 months
  • Stage 2: carrying out late stage preclinical and early clinical work, based on the results of Stage 1. We expect projects to last for up to 24 months

The competition opens on 17 October 2016. The deadline for registration is at noon on 21 December 2016, and the deadline for applications is at noon on 4 January 2017.


To attend our briefing event on 31st October follow this link: 

To join the webcast



To attend